All In MedTech

Device Trial Radar · NCT06340451

Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity

A Multicenter, Randomized, Double-Blind, Sham-Controlled Study Assessing the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 133 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

133

Actual

Start

Jul 11, 2024

Primary completion

Sep 30, 2026

Study completion Sep 30, 2026

Sponsor

Lead sponsor
Pacira Pharmaceuticals, IncNot on our public-company list
Sponsor type
Industry
First posted
Apr 1, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This multicenter, randomized, double-blind, sham-controlled study is designed to evaluate the efficacy and safety of the iovera° system in subjects with upper extremity spasticity. A total of approximately 132 subjects will be enrolled; 88 subjects will receive treatment with the iovera° system and 44 subjects will receive sham treatment (sham iovera° system treatment).

Conditions

  • Spasticity, Cerebral or Spinal Condition

Interventions

  • iovera° systemDevice

    subjects will receive ultrasound-guided iovera° system treatment

  • sham iovera° system treatmentDevice

    subjects will receive ultrasound-guided iovera° sham system treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in the Modified Ashworth Scale score for elbow measured (0 to 4, where lower scores represent normal muscle tone and higher scores represent spasticity)Time frame: at week 13

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Rancho Los Amigos National Rehabilitation Center

    Downey, California

17 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.